Annual EBITDA
-$8.34 M
0.00%
01 December 2023
Summary:
Cadrenal Therapeutics Common Stock annual earnings before interest, taxes, depreciation & amortization is currently -$8.34 millionCVKD annual EBITDA is now at all-time high.CVKD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.41 M
-$14.90 K-0.62%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.41 million, with the most recent change of -$14.90 thousand (-0.62%) on 01 September 2024. Over the past year, it has dropped by -$1.37 million (-132.40%). CVKD quarterly EBITDA is now -1298.84% below its all-time high of -$172.10 thousand, reached on 31 March 2022.CVKD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$7.61 M
-$1.37 M-22.00%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock TTM earnings before interest, taxes, depreciation & amortization is currently -$7.61 million, with the most recent change of -$1.37 million (-22.00%) on 01 September 2024. Over the past year, it has dropped by -$411.50 thousand (-5.72%). CVKD TTM EBITDA is now -4319.58% below its all-time high of -$172.10 thousand, reached on 31 March 2022.CVKD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CVKD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -132.4% | -5.7% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CVKD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at low | -1298.8% | +53.3% | -4319.6% | +8.8% |
| 5 y | 5 years | at high | at low | -1298.8% | +53.3% | -4319.6% | +8.8% |
| alltime | all time | at high | at low | -1298.8% | +53.3% | -4319.6% | +8.8% |
Cadrenal Therapeutics Common Stock EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.41 M(+0.6%) | -$7.61 M(+22.0%) |
| June 2024 | - | -$2.39 M(+43.9%) | -$6.23 M(+28.7%) |
| Mar 2024 | - | -$1.66 M(+45.4%) | -$4.84 M(-41.9%) |
| Dec 2023 | -$8.34 M | -$1.14 M(+10.4%) | -$8.34 M(+15.9%) |
| Sept 2023 | - | -$1.04 M(+3.3%) | -$7.19 M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$1.00 M(-80.6%) | -$7.15 M(+7.8%) |
| Mar 2023 | - | -$5.16 M(+419.0%) | -$6.64 M(+301.5%) |
| Sept 2022 | - | -$993.60 K(+103.9%) | -$1.65 M(+150.7%) |
| June 2022 | - | -$487.40 K(+183.2%) | -$659.50 K(+283.2%) |
| Mar 2022 | - | -$172.10 K | -$172.10 K |
FAQ
- What is Cadrenal Therapeutics Common Stock annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly EBITDA year-on-year change?
- What is Cadrenal Therapeutics Common Stock TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock TTM EBITDA year-on-year change?
What is Cadrenal Therapeutics Common Stock annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CVKD is -$8.34 M
What is the all time high annual EBITDA for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high annual earnings before interest, taxes, depreciation & amortization is -$8.34 M
What is Cadrenal Therapeutics Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CVKD is -$2.41 M
What is the all time high quarterly EBITDA for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$172.10 K
What is Cadrenal Therapeutics Common Stock quarterly EBITDA year-on-year change?
Over the past year, CVKD quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.37 M (-132.40%)
What is Cadrenal Therapeutics Common Stock TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CVKD is -$7.61 M
What is the all time high TTM EBITDA for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high TTM earnings before interest, taxes, depreciation & amortization is -$172.10 K
What is Cadrenal Therapeutics Common Stock TTM EBITDA year-on-year change?
Over the past year, CVKD TTM earnings before interest, taxes, depreciation & amortization has changed by -$411.50 K (-5.72%)